Hyperbilirubinaemia, presenting as jaundice, is a ubiquitous and frequently benign
condition in newborn babies but is a leading cause of hospitalisation in the first week of life …

Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the
potential toxicity of bilirubin, newborn infants must be monitored to identify those who might …

Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the
potential toxicity of bilirubin, newborn infants must be monitored to identify those who might …

Severe neonatal hyperbilirubinemia, defined as total serum bilirubin (TSB)≥ 20 mg/dl, is
associated with a higher risk of permanent neurological sequelae and death. Jaundice can …

Objective To estimate the incidence of neonatal jaundice and hyperbilirubinemia in a poor
urban community in Karachi, where 70% of births occur at home. Methods Home‐based …

Importance Neonatal hyperbilirubinemia can cause lifelong neurodevelopmental
impairment (kernicterus) even in high-resource settings. A better understanding of the …

Objectives: To determine the incidence of severe hyperbilirubinaemia in the newborn, and to
identify associated clinical and demographic variables, and short-term outcomes. Design …

Background: Severe neonatal hyperbilirubinemia, when unmonitored or untreated, can
progress to acute bilirubin encephalopathy (ABE). Initiatives to prevent and eliminate post …

Hyperbilirubinaemia is a ubiquitous transitional morbidity in the vast majority of newborns
and a leading cause of hospitalisation in the first week of life worldwide. While timely and …

Despite efforts to eliminate permanent and irreversible brain damage due to bilirubin
encephalopathy and kernicterus, these conditions continue to accompany us into the third …